Efficacy and safety analysis of the German expanded access program of osimertinib in patients with advanced, T790M‑positive non‑small cell lung cancer

Saved in:
Bibliographic Details
Main Authors: Stratmann, Jan A. (Author) , Michels, Sebastian (Author) , Hornetz, Sofia Emily Tsion (Author) , Christoph, Daniel C. (Author) , Sackmann, Sandra (Author) , Spengle, Werner (Author) , Bischoff, Helge (Author) , Biscaldi-Schäfer, Monica (Author) , Alt, Jürgen (Author) , Müller, Annette (Author) , Laack, Eckart (Author) , Kimmich, Martin (Author) , Griesinger, Frank (Author) , Sebastian, Martin (Author)
Format: Article (Journal)
Language:English
Published: 2018
In: Journal of cancer research and clinical oncology
Year: 2018, Volume: 144, Issue: 12, Pages: 2457-2463
ISSN:1432-1335
DOI:10.1007/s00432-018-2754-x
Online Access:Resolving-System, Volltext: https://doi.org/10.1007/s00432-018-2754-x
Get full text
Author Notes:Jan A. Stratmann · Sebastian Michels· Sofia Hornetz · Daniel C. Christoph, Sandra Sackman, Werner Spengle, Helge Bischof, Monica Schäfer, Jürgen Alt, Annette Müller, Eckart Laack, Martin Kimmich, Frank Griesinger, Martin Sebastian
Description
Physical Description:Online Resource
ISSN:1432-1335
DOI:10.1007/s00432-018-2754-x